Encainide

Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.^[1]

Encainide

Clinical data
Trade names	Enkaid
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a605040
ATC code	C01BC08 (WHO)
Legal status
Legal status	Withdrawn
Identifiers
IUPAC name 4-Methoxy-N-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide
CAS Number	66778-36-7 Y
PubChem CID	48041
DrugBank	DB01228 Y
ChemSpider	43697 Y
UNII	SY3J0147NB
KEGG	D07894 Y
ChEBI	CHEBI:4788 Y
ChEMBL	ChEMBL315838 N
CompTox Dashboard (EPA)	DTXSID0022983
Chemical and physical data
Formula	C22H28N2O2
Molar mass	352.478 g·mol−1
3D model (JSmol)	Interactive image
SMILES COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1
InChI InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25) Y Key:PJWPNDMDCLXCOM-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Synthesis

Synthesis:^[2]<

See also

• Iferanserin
• Cardiac Arrhythmia Suppression Trial